Jan Wimmer, LCSW in North Logan, UT - Social Worker

Jan Wimmer, LCSW is a Social Worker - Clinical based in North Logan, Utah. Jan Wimmer is licensed to practice in Utah (license number 125403-3501) and her current practice location is 186 E 1800 N, North Logan, Utah. She can be reached at her office (for appointments etc.) via phone at (435) 770-1429.

NPI number for Jan Wimmer is 1689104309 and her current mailing address is 285 Stonehenge Dr, Providence, Utah. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1689104309.

Contact Information

	Jan Wimmer, LCSW
	186 E 1800 N, North Logan, UT 84341-2019
	(435) 770-1429
	Not Available

Healthcare Provider's Profile

Full Name	Jan Wimmer
Gender	Female
Speciality	Social Worker - Clinical
Location	186 E 1800 N, North Logan, Utah
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1689104309
Provider Enumeration Date: 06/14/2017
Last Update Date: 06/14/2017

Medical Identifiers

Medical identifiers for Jan Wimmer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1689104309	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YA0400X	Counselor - Addiction (substance Use Disorder)	125403-6008 (Utah)	Secondary
1041C0700X	Social Worker - Clinical	125403-3501 (Utah)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jan Wimmer is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jan Wimmer, LCSW 285 Stonehenge Dr, Providence, UT 84332-9645 Ph: (435) 770-1429	Jan Wimmer, LCSW 186 E 1800 N, North Logan, UT 84341-2019 Ph: (435) 770-1429

News Archive

Bronchiectasis finding reveals COPD patients at mortality risk

Bronchiectasis is independently associated with mortality risk among patients with moderate-to-severe chronic obstructive pulmonary disease, Spanish research shows.

New molecular research shows how antidepressants work

New molecular research shows how chemically diverse drugs used to treat depression and anxiety disorders interact with the protein that transports serotonin in the brain.

Astrocytes help reduce damaging effects of epilepsy

Epileptic fits are like thunderstorms raging in the brain: Nerve cells excite each other in an uncontrolled way so that strong, rhythmic electrical discharges sweep over whole brain regions. In the wake of such a seizure, the nerve cells are severely affected, and permanent damage is possible. The glia, a class of cells that surround the neurons in the brain, was long suspected to contribute to the damaging effects of epilepsy.

Genentech uses Complete Genomics' sequencing service to compare primary lung tumor, adjacent normal tissue

Complete Genomics Inc., a third-generation human genome sequencing company, today announced that Genentech Inc., a wholly owned member of the Roche Group, used the company's sequencing, bioinformatics and analytics services to sequence and compare a patient's primary lung tumor and adjacent normal tissue.

Jan Wimmer, LCSW - Counselor in North Logan, UT